Human SOST/Sclerostin Biotinylated Antibody
R&D Systems, part of Bio-Techne | Catalog # BAM14061
Key Product Details
Species Reactivity
Human
Applications
ELISA Detection (Matched Antibody Pair)
Label
Biotin
Antibody Source
Monoclonal Mouse IgG1 Clone # 220910
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human SOST/Sclerostin
Gln24-Tyr213
Accession # Q9BQB4
Gln24-Tyr213
Accession # Q9BQB4
Specificity
Detects human SOST/Sclerostin in ELISAs. In sandwich immunoassays, 30% cross-reactivity with recombinant mouse SOST is observed and no cross-reactivity or interference with recombinant human BMP-2, -4, -5, -6, or -7 was observed.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for Human SOST/Sclerostin Biotinylated Antibody
Human SOST Sandwich Immunoassay
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS.
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS and NaCl with BSA as a carrier protein.
Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: SOST/Sclerostin
References
- Kusu, N. et al. (2003) J. Biol. Chem. 278:24113.
- Balemans, W. et al. (2001) Hum. Mol. Genet. 10:537.
- Brunkow, M.E. et al. (2001) Am. J. Hum. Genet. 68:577.
Alternate Names
sclerostin, VBCHsclerosteosis
Gene Symbol
SOST
UniProt
Additional SOST/Sclerostin Products
Product Documents for Human SOST/Sclerostin Biotinylated Antibody
Product Specific Notices for Human SOST/Sclerostin Biotinylated Antibody
For research use only
Loading...
Loading...
Loading...